Kamau Therapeutics, a pioneering clinical-stage company focused on next-generation gene correction, has successfully raised $20 million in its latest funding round. With an ambitious mission to transform the landscape of treatment for a wide array of serious and life-threatening diseases, Kamau Therapeutics is at the forefront of gene editing innovation. The company leverages its cutting-edge platform, centered around homology-directed repair (HDR), to develop therapies that deliver precise, targeted gene integration. This groundbreaking approach not only enhances the efficiency and specificity of gene editing but also promises enduring results, paving the way for one-time curative cell therapies. The substantial funding will accelerate Kamau’s research and development efforts, enabling the exploration of therapies aimed at addressing significant unmet medical needs across various genetic disorders. This investment represents a critical step towards realizing Kamau Therapeutics' vision of offering transformative health solutions that can potentially cure diseases once deemed irreversible. As the company continues to advance its technology and pipeline, this funding empowers Kamau Therapeutics to push boundaries and redefine the possibilities in genetic medicine, ultimately striving to improve the quality of life for individuals affected by debilitating conditions. The future looks promising for Kamau Therapeutics, as it embarks on this new chapter with renewed vigor and resources to spearhead revolutionary advancements in the healthcare sector.
Kamau Therapeutics Secures $20 Million Funding for Revolutionary Gene Correction Platform
Get the full Kamau Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Featherless AI
We enable serverless inference via our GPU orchestration and model load-balancing system. We unlock fine-tuning by enabling organizations to size their server fleet to throughput needs, not number of models in the catalogue. See it in action on our public cloud, which offers inference for 10k+ open weight models.
$20.0M Series a
today
Liquid
Liquid's mission is to build the future of trading. Liquid's first product is a trading platform that allows users to long and short any financial instrument with leverage, 24/7.
$18.0M Series a
today
Onsetto
Onsetto powers Structured Activation for business banking, helping financial institutions turn new business accounts into fully activated operating relationships. Opening a business account is only the beginning. The real value comes when operating activity moves; payroll, receivables, payables, and funding. When those flows transition, deposits follow and the relationship becomes primary. Onsetto’s platform seamlessly guides businesses through the process of switching their operating account while giving financial institutions real-time visibility into activation and funding progress. Delivered as a secure, white-label solution that operates alongside existing systems, Onsetto requires no core integration and can be implemented quickly. By helping banks activate operating relationships faster, Onsetto enables financial institutions to capture the Core Operating Account, accelerate business deposit growth, and deepen commercial relationships.
$9.0M Seed
today
General Analysis
General Analysis provides a comprehensive suite of AI safety tools, including run-time guardrails, red-teaming frameworks, interpretability techniques, observability, and more. As AI systems become increasingly capable, their deployment in high-stakes environments poses significant risks—financial, ethical, and otherwise—where errors can lead to substantial consequences. To address these challenges, we offer access to novel tools and methodologies designed to systematically find model failure-modes and enhance model robustness.
$10.0M Seed
today
Kimbal
Founded in 2011, Kimbal Private Limited (formerly Sinhal Udyog Private Limited) is an ISO 9001:2015 certified fastest emerging Indian startup building breakthrough technologies for utilities. Today we function as a trusted technology partner to the largest DISCOMS of India with Made in India end-to-end solutions for their AMI Projects. Our AI-enabled meter reading application - Samaksha, workforce management application - Yukti, and Harmonics analyzer - Tarang, are rising as groundbreaking technologies for utilities worldwide. At the core, Kimbal Technologies is essentially an innovation lab championed by driven technocrats, with raw entrepreneurship as our central pillar. We leverage emerging technologies, data, and exhaustive research to design proven engineering solutions to empower utilities to distribute reliable, secure, and sustainable energy to their end customers with more confidence and control. As we rise to strengthen and expand our operations globally, we have created and continue to cultivate our company culture that stands tall and strong on a motivated and determined workforce. We are an employee-first organization with our unwavering investment in entrepreneurship, mutual trust & respect, and integrity.
$22.0M Series b
today